About dulaglutide
GLP-1 receptor agonist
Used for
- Type 2 diabetes, alongside diet and exercise, to improve blood sugar
- Reducing cardiovascular risk in some adults with type 2 diabetes
Usual adult dose
Usually 0.75 mg injected under the skin once weekly; may increase to 1.5 mg or higher if needed.
Usual dose in children
For children aged 10 years and older with type 2 diabetes: usually 0.75 mg under the skin once weekly; may increase to 1.5 mg.
Common side effects
- Nausea, diarrhea, vomiting, or abdominal pain
- Decreased appetite
- Injection-site reactions
- Low blood sugar, especially with insulin or sulfonylureas
Important warnings
- Pancreatitis has been reported; severe, persistent abdominal pain needs urgent assessment.
- Not recommended with a personal or family history of medullary thyroid cancer or MEN 2.
- May worsen severe stomach-emptying problems; not recommended in severe gastroparesis.
- Dehydration from vomiting or diarrhea can affect kidney function.
Pregnancy
May harm an unborn baby; generally stop when pregnancy is recognized. Discuss plans with a healthcare professional.
Breastfeeding
There is limited information about use during breastfeeding; discuss risks and benefits with a healthcare professional.
Interactions
- Insulin or sulfonylureas increase low-blood-sugar risk.
- Slows stomach emptying and may affect absorption of oral medicines.
- May affect absorption of oral contraceptives and medicines needing close monitoring.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.